ICRA upgrades Indoco Remedies’ long term rating to ‘AA-’

23 Jul 2021 Evaluate

Credit rating agency -- ICRA has upgraded Indoco Remedies’ long term rating to ‘AA-’ from ‘A+’. The outlook on the long-term rating is stable. The short term rating of company has been revised to ‘A1+’ from ‘A1’.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

321.05 1.35 (0.42%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.